home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Study Offers First Insights into BCL-6 Regulation of Type 2 Inflammation

 
  September, 1 2000 2:47
your information resource in human molecular genetics
 
     
Repressor controls chemokines

Nature Immunology pages 214-220, News and Views page 189.

The BCL6 gene is implicated in B cell lymphomas, in which the regulation of many genes goes haywire.

But the protein BCL-6 doesn’t turn genes on that shouldn’t be on ­ it turns genes off. Mice that lack BCL-6 get an aggressive general inflammation that leads to death. Vital organs such as the spleen and liver are severely affected, and abnormal numbers of immune cells are present in these mice. The pattern of cells present ­ monocytes, eosinophils, type 2 helper T (TH2) cells, mast cells and B cells that produce the “allergy antibody” IgE ­ indicate that it is a type 2 inflammation.

How does the loss of one protein, BCL-6, lead to this state? In the September issue of Nature Immunology [Vol. 1, No. 3], researchers from Indiana University report the first insights into BCL-6 regulation of type 2 inflammation. The inflammation in BCL-6­deficient mice required cells such as macrophages, which produced a much greater amount of certain factors. Called chemokines, these factors attract the cell types typically found in type 2 inflammation.

The authors went on to show that the genes for three chemokines, MCP-1, MCP-3 and MRP-1, are repressed by BCL-6 in normal macrophages. In mice that lack BCL-6, the exuberant expression of these chemokines leads to severe TH2-type inflammation and eventual death of the mice.

A News & Views was written on this paper by Paul Rothman of Columbia University.

Contact Information:

Article:
Alexander L. Dent
Indiana University
School of Medicine
Department of Microbiology and Immunology
The Walther Oncology Center
Indianapolis, IN 46202
Tel: 317-274-7524
Fax: 317-274-7592
E-mail: adent2@iupui.edu

N&V:
Paul Rothman
Columbia University
Dept of Microbiology and Medicine
630 W 168th St
New York, NY 10032
Tel: 212 305-1984
Fax: 212 305-1870
E-mail: pbr3@columbia.edu

(C) Nature Immunology, press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.